2012 to 2000 Office AssistantCITIGROUP New York, NY 2006 to 2009 Business Analyst, ConsultantAON New York, NY 2004 to 2006 Document Production Specialist, Client Services DivisionSAKS FIFTH AVENUE New York, NY 2003 to 2004 Media CoordinatorTHOMAS PUBLISHING New York, NY 2000 to 2003 Editorial Assistant
Education:
STATE UNIVERSITY OF NEW YORK May 2000 Bachelor of Arts in EnglishBINGHAMPTON UNIVERSITY Binghamton, NY 1996 to 2000
Oct 2009 to Present Administrative AssistantSelf-employed New York, NY Nov 2004 to Dec 2009 Online MerchantThompson & Company, CPAs & Consultants Brooklyn, NY Jun 2009 to Sep 2009 Administrative InternHamilton-Madison House New York, NY Oct 2007 to Dec 2007 Volunteer (NYCares.org)
Education:
Berkeley College New York, NY 2011 to 2013 B.B.A. in Health Services ManagementProfessional Business College New York, NY Nov 2007 to Mar 2009 A.O.S. in Business Management
Skills:
Keyboarding: 85 wpm Proficient in Microsoft Office Suite 2003, 2007, & 2010, and Windows XP, Vista, & 7 Familiarity with Intuit QuickBooks Cantonese conversant; Spanish reading comprehension
Dr. Lee graduated from the Southern Illinois University School of Medicine in 1994. She works in Campbell, CA and specializes in Internal Medicine. Dr. Lee is affiliated with Kaiser Permanente Santa Clara Medical Center.
Dr. Lee graduated from the Saint Louis University School of Medicine in 1998. She works in Manhattan Beach, CA and 1 other location and specializes in Obstetrics & Gynecology. Dr. Lee is affiliated with Cedars-Sinai Medical Center.
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K031/336 A61K038/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating a parasitic infection, a lymphoid malignancy or an autoimmune disorder in a subject by administering to the subject a therapeutically effective amount of an angiogenesis inhibitor compound comprising a MetAP-2 inhibitory core coupled to a peptide.
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US
The present invention provides angiogenesis inhibitor compounds comprising a MetAP-2 inhibitory core coupled to a peptide, as well as pharmaceutical compositions comprising the angiogenesis inhibitor compounds and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an angiogenic disease, e. g. , cancer, in a subject by administering to the subject a therapeutically effective amount of one or more of the angiogenesis inhibitor compounds of the invention.
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
The present invention provides angiogenesis inhibitor compounds comprising a MetAP-2 inhibitory core coupled to a peptide, as well as pharmaceutical compositions comprising the angiogenesis inhibitor compounds and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an angiogenic disease, e. g. , cancer, in a subject by administering to the subject a therapeutically effective amount of one or more of the angiogenesis inhibitor compounds of the invention.
Methionine Aminopeptidase-2 Inhibitors And Methods Of Use Thereof
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles Michael Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating, parasitic infections, thymoma, and lymphoid malignancies in a subject by administering to the subject a therapeutically effective amount of one or more of the compounds of the invention.
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - Edison NJ, US Charles M. Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating an autoimmune disorder (e. g. , lupus erythematosus, multiple sclerosis, myasthenia gravis, vasculitis and diabetes mellitus) in a subject by administering to the subject a therapeutically effective amount of one or more compounds of the invention.
Methionine Aminopeptidase-2 Inhibitors And Methods Of Use Thereof
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - New York NY, US Charles M. Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals Incorporated - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides methods of treating a lymphoma (e. g. , a T-cell lymphoma or a B-cell lymphoma) in a subject by administering to the subject a therapeutically effective amount of one or more of the compounds of the invention, for example, compounds of formulae I and XV:.
Therapeutic Agents And Methods Of Use Thereof For The Treatment Of Melanoma
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - New York NY, US Charles M. Cook - Mendham NJ, US Jens Birktoft - New York NY, US Barry Morgan - Franklin MA, US Christopher C. Arico-Muendel - West Roxbury MA, US
Assignee:
Praecis Pharmaceuticals, Inc. - Waltham MA
International Classification:
A61K 31/336 A61K 38/08
US Classification:
514 2, 514 16, 514475, 514478, 514588
Abstract:
The present invention provides angiogenesis inhibitor compounds comprising a MetAP-2 inhibitory core coupled to a peptide, as well as pharmaceutical compositions comprising the angiogenesis inhibitor compounds and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an angiogenic disease, e. g. , cancer, in a subject by administering to the subject a therapeutically effective amount of one or more of the angiogenesis inhibitor compounds of the invention.
Therapeutic Agents And Methods Of Use Thereof For The Modulation Of Angiogenesis
Gary L. Olson - Mountainside NJ, US Christopher Self - West Caldwell NJ, US Lily Lee - New York NY, US Charles M. Cook - Mendham NJ, US Jens Birktoft - New York NY, US
The present invention provides angiogenesis inhibitor compounds comprising a MetAP-2 inhibitory core coupled to a peptide, as well as pharmaceutical compositions comprising the angiogenesis inhibitor compounds and a pharmaceutically acceptable carrier. The present invention also provides methods of treating an angiogenic disease, e. g. , cancer, in a subject by administering to the subject a therapeutically effective amount of one or more of the angiogenesis inhibitor compounds of the invention.
News
Tropical Storm Sandy cuts power across NJ; roads closed in Pa.
The Manayunk Diner at the bottom of Main Street was also open "Koreans never close for anything," said Lily Lee, the owner's daughter but business was slow. Benjamin Kall came in for what might be that last "nice, full breakfast" for a while.